Skip to content

A Study To Evaluate Role of Brahmyadi churna and Ashvagandha churna with Satwavjaya chikitsa in Anxiety.

A Randomized open labelled comparative clinical study to evaluate the combined efficacy of Brahmyadi churna and Asvagandha churna with Satwavjaya chikitsa in the management of Chittodvega with special reference to Generalised Anxiety Disorder. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070479
Enrollment
30
Registered
2024-07-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

None listed

Sponsors

Dr Anupam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects fulfilling criteria based on DSM-5 and those getting score between 8-23 in Hamilton Anxiety Rating Scale will be included in the study. 2.Subjects suffering from GAD for a minimum period of atleast 6 months 3.Subjects between age group of 20 to 60 years irrespective of gender. 4.Subjects willing to sign consent form.

Exclusion criteria

Exclusion criteria: 1.Subjects on use of anxiolytics or antidepressants in the previous 6 months. 2.Subjects diagnosed with other psychiatric illnesses like mood disorder, psychosis, depression etc. from past 12 months. 3.Subjects suffering from Generalised anxiety disorder associated with other serious systemic illnesses that would interfere with the treatment. 4.Subjects with uncontrolled hypertension , diabetes mellitus , thyroid dysfunction, renal dysfunction, organic mental disorder or psychoactive-substance related disorder, such as excess consumption of alcohol, amphetamine-like substances, or withdrawal from benzodiazepines. 5.Pregnant and Lactating Women.

Design outcomes

Primary

MeasureTime frame
Significant decrease in signs and symptoms of GAD assessment based on Hamilton Anxiety rating ScaleTimepoint: Before intervention- 0th After intervention- 28th Follow Up- 43rd day.

Secondary

MeasureTime frame
Generation of in depth analysed data on different aspect of Disease . Generation of Data on possible unexpected drug reactionTimepoint: Before intervention- 0th After intervention- 28th Follow Up- 43rd day.

Countries

India

Contacts

Public ContactDr Gopalakrishna G

Sri Sri College of Ayurvedic Science and Research Hospital, Bangalore

lakshmimp1981@gmail.com08076370183

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026